Secretome Therapeutics raises $20.4 million in fresh funding
Secretome Therapeutics, a biotechnology company developing therapies derived from neonatal cardiac progenitor cells (nCPCs) for cardiovascular diseases, raised $20.4 million in funding. Investors were not … Read more